Kyle Berkman, Director at Intrepid Investment Bankers, was featured as a panelist in the Los Angeles Times Studios Healthcare & Life Sciences Roundtable, published in the LA Times on July 21, 2025.
In the feature, Kyle offered key insights into the forces reshaping the healthcare, biotech, and life sciences sectors from an M&A perspective. His commentary highlighted several trends defining the industry's evolution in 2025:
- AI in Clinical Workflows: Kyle emphasized AI’s growing impact on diagnostics, workflow efficiency, and patient engagement.
“Numerous studies have confirmed that AI does a better job at complex disease diagnosis than human doctors, and medical software/EHR providers are racing to incorporate these capabilities into clinical workflows to establish better guardrails and improve diagnostic accuracy.”
- Investor Interest in Behavioral Health: Behavioral health, including mental health and ABA services, continues to attract strong investor interest, driven by rising demand, particularly among younger populations.
- Drivers of Premium Valuations: Growth, scalability, recurring revenue, and strong leadership teams are among the top attributes driving higher valuations in healthcare deals.
- Consumer-Driven Care Expectations: With rising demand for fast, personalized, tech-enabled care, providers must adapt or risk falling behind in a competitive market.
- The Future of Health Optimization: Tools that help consumers track biomarkers and detect conditions early are redefining how people engage with their health.
To read the full roundtable, visit the article here.